Structures by: Brimble M. A.
Total: 31
C33H38NO5
C33H38NO5
Organic Chemistry Frontiers (2019) 6, 16 2954
a=9.1302(3)Å b=9.1578(5)Å c=10.2260(4)Å
α=108.986(4)° β=98.417(3)° γ=114.037(4)°
7,6-spirolactam
C12H21NO
Organic letters (2009) 11, 4 963-966
a=8.5417(2)Å b=10.2807(2)Å c=12.6400(3)Å
α=102.850(1)° β=90.091(1)° γ=91.488(1)°
(4R,5S)-3-((S)-3-(5-(benzyloxy)-7-methoxy-2-methyl- 4-oxo-4H-chromen-6-yl)-2-methylpropanoyl)-4-methyl-5- phenyloxazolidin-2-one
C32H31NO7
Organic letters (2013) 15, 3 658-661
a=10.37930(10)Å b=10.37930(10)Å c=25.3520(7)Å
α=90.00° β=90.00° γ=90.00°
C24H26NO6S
C24H26NO6S
Organic & biomolecular chemistry (2019) 17, 10 2705-2714
a=11.1279(2)Å b=6.76700(10)Å c=29.5619(4)Å
α=90° β=97.0730(10)° γ=90°
C20H22O3S
C20H22O3S
Organic & biomolecular chemistry (2013) 11, 31 5147-5155
a=10.3509(6)Å b=11.7545(7)Å c=15.0554(9)Å
α=90.00° β=90.00° γ=90.00°
C20H22O3S
C20H22O3S
Organic & biomolecular chemistry (2013) 11, 31 5147-5155
a=8.5909(4)Å b=10.8998(5)Å c=9.6997(4)Å
α=90.00° β=104.215(3)° γ=90.00°
Trans-2-(2-Naphthyl)-3-(phenylselenyl)tetrahydropyran
C21H20OSe
Acta Crystallographica Section E (2002) 58, 8 o931-o932
a=8.1766(2)Å b=8.8854(2)Å c=23.0888(3)Å
α=90.00° β=90.00° γ=90.00°
Cis-2-(2-Methoxyphenyl)-3-(phenylselenyl)tetrahydropyran
C18H20O2Se
Acta Crystallographica Section E (2002) 58, 8 o933-o934
a=7.1823(4)Å b=7.7739(4)Å c=13.9367(7)Å
α=97.180(2)° β=97.654(2)° γ=94.793(2)°
5,8'-Dimethoxy-3H-1-benzofuran-2-spiro-2'-chroman
C18H18O4
Acta Crystallographica Section E (2005) 61, 8 o2748-o2749
a=5.75930(10)Å b=10.68810(10)Å c=12.31220(10)Å
α=98.8570(10)° β=100.2080(10)° γ=95.5100(10)°
C34H33BrO7
C34H33BrO7
Acta Crystallographica Section E (2001) 57, 1 o28-o29
a=19.5150(10)Å b=23.667(2)Å c=6.541(2)Å
α=90.00° β=90.00° γ=90.00°
(1S,2S)-1-{2-[(4-methoxybenzyl)oxy]ethyl}-2-methyl-3-butenyl (1S,4R)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxylate
C25H34O6
Acta Crystallographica Section E (2005) 61, 1 o6-o7
a=6.82970(10)Å b=12.0970(2)Å c=27.8762(4)Å
α=90.00° β=90.00° γ=90.00°
C17H16O3
C17H16O3
Acta Crystallographica Section E (2005) 61, 4 o1123-o1124
a=10.3982(7)Å b=5.7749(4)Å c=11.2480(8)Å
α=90.00° β=96.1320(10)° γ=90.00°
6,8'-Dimethoxy-2,2'-spirobichroman
C19H20O4
Acta Crystallographica Section E (2005) 61, 4 o910-o911
a=5.8149(5)Å b=10.9359(10)Å c=12.9304(12)Å
α=73.684(2)° β=86.3830(10)° γ=79.589(2)°
(2''S,5''R,7''S)-2-[2'-(2''-Methyl-1'',6''-dioxaspiro[4.5]dec-7''- yl)ethylsulfonyl]-1,3-benzothiazole
C18H23NO4S2
Acta Crystallographica Section E (2006) 62, 3 o1187-o1188
a=7.81320(10)Å b=7.37840(10)Å c=15.89840(10)Å
α=90.00° β=90.6280(10)° γ=90.00°
8'-Methoxy-3H-spiro[1-naphthofuran-2,2'-chromane]
C21H18O3
Acta Crystallographica Section E (2006) 62, 3 o1075-o1076
a=5.98580(10)Å b=13.2104(2)Å c=20.4727(3)Å
α=90.00° β=97.0660(10)° γ=90.00°
Cis-14-phenylsulfonyl-1,7,9-trioxadispiro[5.1.5.3]hexadecane
C19H26O5S
Acta Crystallographica Section C (1993) 49, 10 1857-1859
a=5.856(5)Å b=21.758(4)Å c=14.495(4)Å
α=90.0° β=98.16(5)° γ=90.0°
(1<i>R</i>,1'<i>R</i>,3<i>S</i>,3'<i>S</i>)-5,5',10,10'-Tetramethoxy-1,1',3,3'- tetramethyl- 3,3',4,4'-tetrahydro-1<i>H</i>,1'<i>H</i>-8,8'-bi[benzo[<i>g</i>]isochromene]
C34H38O6
Acta Crystallographica Section E (2008) 64, 4 o758
a=8.8773(2)Å b=13.9298(2)Å c=23.1234(4)Å
α=90.00° β=90.00° γ=90.00°
7,6-spirolactam
C12H21NO
Acta Crystallographica Section E (2008) 64, 6 o1151
a=8.5417(2)Å b=10.2807(2)Å c=12.6400(3)Å
α=102.8500(10)° β=90.0910(10)° γ=91.4880(10)°
3-Allyl-2-hydroxy-5,6,8-trimethoxynaphthalene-1,4-dione
C16H16O6
Acta Crystallographica Section E (2008) 64, 10 o1929
a=4.68110(10)Å b=12.6577(3)Å c=23.3392(5)Å
α=90.00° β=90.00° γ=90.00°
(+-)-<i>N</i>-(3-hydroxy-1,2-diphenylpropyl)-4-methylbenzenesulfonamide
C22H23NO3S
Acta Crystallographica Section E (2008) 64, 10 o1990
a=39.4702(16)Å b=5.4270(2)Å c=17.4287(7)Å
α=90.00° β=91.028(2)° γ=90.00°
(+-)-1-{8'-(<i>tert</i>-Butyldiphenylsilyloxymethyl)-1',7'- dioxaspiro[5.5]undecan-2'-yl}uridine
C30H38N2O5Si
Acta Crystallographica Section E (2008) 64, 4 o715
a=14.7960(2)Å b=12.5092(2)Å c=15.09350(10)Å
α=90.00° β=99.4200(10)° γ=90.00°
8-Aza-14-phenylisoxazolo[2,3-<i>g</i>]spiro[5.6]dodecane
C19H27NO
Acta Crystallographica Section E (2008) 64, 8 o1535
a=9.85160(10)Å b=10.45600(10)Å c=16.09570(10)Å
α=101.0580(10)° β=92.8330(10)° γ=96.5270(10)°
(+-)-Cyclohexane-1,2-diyl bis(4-nitrobenzoate)
C20H18N2O8
Acta Crystallographica Section E (2008) 64, 11 o2174
a=12.6510(2)Å b=12.2720(2)Å c=13.2186(2)Å
α=90.00° β=108.8300(10)° γ=90.00°
Cis-endo-threo-norbormide
C33H25N3O3
Acta Crystallographica Section C (2004) 60, 5 o374-o376
a=15.433(4)Å b=11.437(3)Å c=17.048(5)Å
α=90.00° β=115.427(3)° γ=90.00°
Trans-endo-threo-norbormide ethyl acetate hemi-solvate
C33H25N3O3,0.5C4H8O2
Acta Crystallographica Section C (2004) 60, 5 o374-o376
a=17.999(3)Å b=12.614(2)Å c=13.063(2)Å
α=90.00° β=110.834(2)° γ=90.00°
C43H66O10,H2O
C43H66O10,H2O
Acta Crystallographica Section C (2001) 57, 1 95-96
a=12.373(2)Å b=31.939(2)Å c=11.064(2)Å
α=90.00° β=90.00° γ=90.00°
(1<i>R</i>,6<i>R</i>,13<i>R</i>,18<i>R</i>)-(<i>Z</i>,<i>Z</i>)- 1,18-Bis[(4<i>R</i>)-2,2-dimethyl-1,3-dioxolan-4-yl]-3,16-dimethylene- 8,20-diazadispiro[5.6.5.6]tetracosa-7,19-diene
C34H54N2O4
Acta Crystallographica Section E (2010) 66, 7 o1778-o1779
a=6.87100(10)Å b=10.1701(2)Å c=11.7947(2)Å
α=79.1430(10)° β=88.0430(10)° γ=83.8550(10)°
Psychrophilin E
C25H24N4O4
The Journal of organic chemistry (2016) 81, 17 7635-7643
a=12.3522(3)Å b=12.7928(4)Å c=13.7288(5)Å
α=90° β=90° γ=90°
C16H26O2Si
C16H26O2Si
The Journal of organic chemistry (2017) 82, 20 11225-11229
a=6.3872(5)Å b=13.6568(9)Å c=18.5349(12)Å
α=90° β=90° γ=90°
C16H26O2Si
C16H26O2Si
The Journal of organic chemistry (2017) 82, 20 11225-11229
a=6.9230(12)Å b=9.2252(16)Å c=13.527(2)Å
α=85.237(7)° β=84.232(7)° γ=76.806(7)°
Citreoviranol
C15H18O6
The Journal of organic chemistry (2016) 81, 18 8343-8350
a=7.1669(4)Å b=7.6027(4)Å c=13.8637(8)Å
α=94.992(4)° β=92.691(4)° γ=93.826(4)°